Mien‐Chie Hung
Impact in
- Oncology top 0.01%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
Papers in
- Oncology 372
- HER2/EGFR in Cancer Research 165
- Cancer Immunotherapy and Biomarkers 75
- Cancer-related Molecular Pathways 66
- Cancer Cells and Metastasis 38
- Cancer Research 109
- NF-κB Signaling Pathways 25
- Co-authors
- Weiya Xia (104 shared papers)Dihua Yu (72 shared papers)Binhua Peter Zhou (20 shared papers)Gabriel N. Hortobágyi (53 shared papers)Jennifer L. Hsu (68 shared papers)Robert A. Weinberg (4 shared papers)Yongkun Wei (45 shared papers)Hirohito Yamaguchi (56 shared papers)
- Journals
- Cancer Research (53 papers)Oncogene (51 papers)Cancer Cell (35 papers)Journal of Biological Chemistry (32 papers)Nature Communications (25 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Mien‐Chie Hung
813 papers receiving 82.8k citations
Mien‐Chie Hung's Hit Papers
Peers
Comparison fields: 5 of 176
- Oncology 27.2k
- Cancer Research 12.1k
- Molecular Biology 29.9k
- Pulmonary and Respiratory Medicine 6.9k
- Cell Biology 2.9k
Countries citing papers authored by Mien‐Chie Hung
This map shows the geographic impact of Mien‐Chie Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mien‐Chie Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mien‐Chie Hung more than expected).
Fields of papers citing papers by Mien‐Chie Hung
This network shows the impact of papers produced by Mien‐Chie Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mien‐Chie Hung. The network helps show where Mien‐Chie Hung may publish in the future.
Co-authors
The 25 scholars most cited alongside Mien‐Chie Hung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 825 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Hit paper breakdown → | 2004 | 1523 |
| 2 | Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition Hit paper breakdown → | 2004 | 1407 |
| 3 | Requirement for neuregulin receptor erbB2 in neural and cardiac development Hit paper breakdown → | 1995 | 1080 |
| 4 | The neu oncogene encodes an epidermal growth factor receptor-related protein Hit paper breakdown → | 1986 | 1004 |
| 5 | Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells Hit paper breakdown → | 2001 | 957 |
| 6 | Nuclear localization of EGF receptor and its potential new role as a transcription factor Hit paper breakdown → | 2001 | 917 |
| 7 | Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 Hit paper breakdown → | 1986 | 910 |
| 8 | An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer Hit paper breakdown → | 2008 | 908 |
| 9 | Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity Hit paper breakdown → | 2016 | 908 |
| 10 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression Hit paper breakdown → | 2017 | 850 |
| 11 | Mechanisms Controlling PD-L1 Expression in Cancer Hit paper breakdown → | 2019 | 836 |
| 12 | BAP1 links metabolic regulation of ferroptosis to tumour suppression Hit paper breakdown → | 2018 | 835 |
| 13 | HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Hit paper breakdown → | 2001 | 789 |
| 14 | IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a Hit paper breakdown → | 2004 | 781 |
| 15 | PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis Hit paper breakdown → | 2020 | 768 |
| 16 | Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer Hit paper breakdown → | 2009 | 747 |
| 17 | Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer Hit paper breakdown → | 2006 | 739 |
| 18 | Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. | 1997 | 732 |
| 19 | Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer Hit paper breakdown → | 2013 | 697 |
| 20 | 2000 | 694 |
About Mien‐Chie Hung
Mien‐Chie Hung is a scholar working on Oncology, Cancer Research, Molecular Biology, Genetics and Cell Biology, having authored 825 papers that have together received 84.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (165 papers), Cancer Immunotherapy and Biomarkers (75 papers), Cancer-related Molecular Pathways (66 papers), Virus-based gene therapy research (53 papers), Cancer Cells and Metastasis (38 papers), PI3K/AKT/mTOR signaling in cancer (37 papers), Cell death mechanisms and regulation (26 papers) and NF-κB Signaling Pathways (25 papers). The work is most often cited by research in Oncology (27.2k citations), Cancer Research (12.1k citations), Molecular Biology (29.9k citations), Pulmonary and Respiratory Medicine (6.9k citations) and Cell Biology (2.9k citations). Mien‐Chie Hung has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Weiya Xia, Dihua Yu, Binhua Peter Zhou, Gabriel N. Hortobágyi, Jennifer L. Hsu, Robert A. Weinberg, Yongkun Wei, Hirohito Yamaguchi, Jung-Mao Hsu and Cornelia I. Bargmann. Their work appears in journals such as Cancer Research, Oncogene, Cancer Cell, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.